HIV-1 drug-resistance and drug-dependence
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Retrovirology
- Vol. 4 (1) , 78
- https://doi.org/10.1186/1742-4690-4-78
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Mutation in Alpha Helix 3 of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A Resistant and Dependent: Rescue by a Second-Site Substitution in a Distal Region of CAJournal of Virology, 2007
- Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility ofHuman Immunodeficiency Virus Type 1 to Other Classes of Entry InhibitorsJournal of Virology, 2007
- Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K)AIDS, 2007
- HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entryVirology, 2006
- Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoproteinRetrovirology, 2006
- In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)Journal of Virology, 2006
- Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected PatientsJournal of Virology, 2006
- θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle FormationJournal of Biological Chemistry, 2006
- Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1Journal of Medical Virology, 2005
- Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2005